The "Immunotherapy in Oncology Patent Landscape Report and Forecast 2024-2032" report has been added to ...

A new immunotherapy target called a cryptic antigen may be key in helping the immune system fight ovarian cancer.

Asthma inhalers are one type of allergic asthma medication that can help when symptoms begin. Find out which other types of ...

Mayo Clinic researchers have discovered a new immunotherapy target, a cryptic antigen, that may be key in helping the immune system fight tumors in ovarian cancer. The study, published in Science ...

It delves into patent filing trends, highlighting key players and their contributions to advancing immunotherapy. The report identifies emerging therapeutic targets and assesses the competitive ...

Versamune ® is a registered trademark of PDS Biotechnology Corporation. Investor Contact: Mike Moyer LifeSci Advisors Phone +1 (617) 308-4306 Email: mmoyer@lifesciadvisors.com ...

New findings could help make immunotherapies for brain cancer more effective. The team analyzed almost 200,000 individual immune cells in tumor samples taken from patients with glioma, the most common ...

An experimental treatment for an aggressive and lethal brain cancer has been published in Nature Medicine, paving the way for ...

A refined use of mutations to guide immunotherapy decisions Several key ... they represent a compelling target for the development of vaccines, CAR T cells and other immune-based therapies.